Liu et al. characterized the presence of a “tumor immune barrier” consisting of CAFs and secreted phosphoprotein (SPP1)+ macrophages that seemingly limits the infiltration of cytotoxic T cells into the tumor and is linked with resistance to immunotherapy [112]. Here, SPP1 is linked to neoplasm.